echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Organic Chemistry Topics > Organic Chemistry Products News > The Upstream and Downstream products of TRI-TERT-BUTYL 1 4 7 10-TETRAAZACYCLONONANE

    The Upstream and Downstream products of TRI-TERT-BUTYL 1 4 7 10-TETRAAZACYCLONONANE

    • Last Update: 2023-04-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    TRI-TERT-BUTYL 1 4 7 10-TETRAAZACYCLONONANE, also known as TBT, is a type of white powder that is widely used in the chemical industry.
    It is a synthetic organic compound that is primarily used as a catalyst in the production of a variety of chemicals, including polypropylene, polyethylene, and other polymers.


    Upstream and Downstream Products of TBT


    The production of TBT involves a number of upstream and downstream products.
    Upstream products are those that are used to produce TBT, while downstream products are those that are produced using TBT as a catalyst.


    One of the primary upstream products used in the production of TBT is dimethylformamide (DMF), which is used as a solvent during the manufacturing process.
    Other upstream products include tetrabutylammonium salts, metal carboxylates, andBasic-D anion exchange resin.


    Once TBT is produced, it is used as a catalyst in the production of downstream products.
    One of the most common downstream products produced using TBT is polypropylene, which is a type of plastic commonly used in packaging materials, textiles, and other products.
    Other downstream products produced using TBT include polyethylene, polyvinyl chloride (PVC), and other types of polymers.


    The use of TBT as a catalyst in the production of downstream products is a critical aspect of the chemical industry.
    Without TBT, the production of these products would not be possible on a large scale.


    Potential Health Risks of TBT


    While TBT is an essential component of the chemical industry, it is also a potential health risk to those who work with it.
    TBT has been classified as a possible human carcinogen by the International Agency for Research on Cancer (IARC), based on evidence that it can cause cancer in animals.


    Additionally, TBT can also cause skin irritation, respiratory problems, and other health issues in those who are exposed to it.
    As a result, it is important for those who work with TBT to take appropriate safety precautions to minimize their exposure to the chemical.


    Conclusion


    TBT is an essential component of the chemical industry, and its use as a catalyst in the production of a variety of downstream products is critical to the industry.
    However, it is also a potential health risk to those who work with it, and appropriate safety precautions must be taken to minimize exposure to the chemical.


    Overall, TBT is a complex and essential compound in the chemical industry, and it will continue to play an important role in the production of a wide range of products for years to come.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.